SCHEMBL6913155

SCHEMBL6913155

O=C(Cl)C(Cl)=Cc1ccccc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
ALOX15 P16050 1/20 0.48
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
KDM4E B2RXH2 3/20 0.42
HPGD P15428 2/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
HMGB1 P09429 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA9 Q16790 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
CA14 Q9ULX7 1/20 0.42
MAPT P10636 3/20 0.41
HDAC8 Q9BY41 1/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8058928 0.84 ALDH1A1 (0.52) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL405156 0.76 ALDH1A1 (0.52) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL2401353 0.76 ALDH1A1 (0.52) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL70201 0.74 ALDH1A1 (0.62) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL8902281 0.74 ALDH1A1 (0.62) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL8580453 0.74 ALDH1A1 (0.62) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL70202 0.74 ALDH1A1 (0.62) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL20448823 0.73 ALDH1A1 (0.59) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
Benzene SCHEMBL28103329 0.73 ALDH1A1 (0.59) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E
SCHEMBL29556927 0.73 ALDH1A1 (0.59) ALDH1A1ALOX15CYP1A2CYP2C9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689899-B2 HYDROGENATION OF THE CORRESPONDING DINITRO COMPOUNDS KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2004-02-10 US disclosed
US-20020019558-A1 Diamine and acid anhydride KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2002-02-14 US disclosed
US-6303742-B1 CHARACTERIZED BY A CINNAMOYL GROUP OR A DERIVED CINNAMOYL GROUP INCORPORATED THEREIN AND BY PHOTO-REACTIVITY AND HEAT-REACTIVITY WHICH ARE INHERENT IN THE CINNAMOYL GROUP. KANEKAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2001-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019558-A1 Diamine and acid anhydride CA1, ASIC1, CA4 ALDH1A1 116/4885ALOX15 3177/4885CYP1A2 2692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.